A detailed history of Sofinnova Investments, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 203,271 shares of RVMD stock, worth $11.5 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
203,271
Previous 455,099 55.33%
Holding current value
$11.5 Million
Previous $17.7 Million 47.85%
% of portfolio
0.87%
Previous 0.98%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$36.92 - $47.94 $9.3 Million - $12.1 Million
-251,828 Reduced 55.33%
203,271 $9.21 Million
Q2 2024

Aug 09, 2024

BUY
$30.14 - $40.68 $13.7 Million - $18.5 Million
455,099 New
455,099 $17.7 Million
Q2 2023

Aug 14, 2023

BUY
$20.28 - $27.0 $6.83 Million - $9.09 Million
336,539 Added 183.06%
520,377 $13.9 Million
Q1 2023

May 11, 2023

BUY
$20.76 - $30.09 $3.82 Million - $5.53 Million
183,838 New
183,838 $3.98 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.